Ergoteles LLC Genprex, Inc. Transaction History

Ergoteles LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.21 - $2.7 $90,228 - $201,336	-74,569 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.59 - $3.36 $151,336 - $196,328	-58,431 Reduced 43.93%	74,569 $200,000
Q2 2021 Aug 12, 2021	BUY	$3.11 - $4.87 $413,630 - $647,710	133,000 New	133,000 $446,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $39.9M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.